| 2003 | |
| Yann GODFRIN | |
Chargement de la carte ... |
|
| 3 | |
| 3 | |
| Non cotée | |
| 0 | |
| 2 | |
| 0.5 | |
| 0.4 | |
| www.neuronax.com | |
| Neuronax is a biopharma company dedicated to the neurological disorders. Our first product (NX210), close to clinical trial in human, is a peptide able to induce regrowing of nerves. The applications are to restore after traumatic events as as to be efficient in neurological disease. |
Fiche créée le 12/07/2021 par C Chloay vue 3 fois.